Assessment of the Efficacy of Carnipure® AAS on Body Composition, Muscle Thickness, and Strength Adaptations in Healthy Men

This study is a 12-week randomized active control trial that is investigating the effects of Carnipure(R) AAS on muscle hypertrophy, body composition, and muscular strength adaptations in healthy men performing a resistance training program.

Inclusion Criteria:Healthy male subjects 18-40 years oldRecreationally trained (>6-months but <1-year of training experience)Not currently consuming any ergogenic supplements or performance enhancing drugsBody mass index (BMI) 18-29 kg/m2No recent injuries that would contraindicate participation in a resistance training programWilling and able to give written informed consentAble to read, understand, sign and date the informed consent document (English only)Able and willing to comply with the schedule visit(s) and study requirements.Exclusion Criteria:Currently taking (within the past 30 days) ergogenic dietary supplements including, creatine, protein, amino acids, or stimulants other than caffeine (yohimbe, ephedrine, etc.)Currently taking performance enhancing drugs (testosterone or other anabolic-androgenic steroids), human growth hormone, insulin, etc.History or current malignancyReceiving chemotherapy agents or radiation treatmentsMusculoskeletal disease (muscular dystrophy, arthritis, etc.)Recent (<3-months) musculoskeletal injuriesBMI <18 or >30 kg/m2Diagnosis of a terminal illnessUse of prescription medications that influence muscle anabolism (i.e., prescription hormone therapies, etc.)History of alcohol abuseHistory or current drug abuseHistory or current cigarette smoke (including vaping) within the past 14 days from the screening visitInsulin-dependent diabetes and/or metformin useChronic kidney or liver diseaseHas significant concurrent illnesses (controlled or uncontrolled), such as diabetes, lupus, epilepsy, or cardiac disorders, hepatitis B/C, HIV, serious mental health illness such as dementia or schizophrenia; psychiatric hospitalization in the past two years, or other, which in the opinion of the investigator, such conditions might be aggravated as a result of treatmentThe investigator feels that for any reason the subject is not eligible to participate in the studyHistory of uncontrolled cardiovascular disease (i.e., myocardial infarction, hypertension, hypercholesterolemia, peripheral vascular disease, other)Developmental disability or cognitive impairment that would preclude adequate comprehension of the informed consent form and/or ability to follow study subject requirement and/or record the necessary study measurementsA family member of the investigator or an employee of the investigatorParticipation in any other investigational study within 30 days prior to consent.